FREMONT, Calif., Feb. 23 /PRNewswire-FirstCall/ -- Abgenix, Inc.
(Nasdaq: ABGX) today announced that the company will participate at the
SunTrust Robinson Humphrey "Off The Cuff" Therapeutics Conference on
Tuesday, March 1, 2005 at 12:15 p.m. PT, 3:15 p.m. ET. The presentation will
be webcast live and may be accessed by visiting the Abgenix website at
http://www.abgenix.com. A replay of the webcast will also be available on the
company's website until Wednesday, March 15, 2005.
Dr. Gisela Schwab, chief medical officer of Abgenix, and H. Ward Wolff,
chief financial officer, will discuss the company's antibody drug development
activities.
About Abgenix
Abgenix is a biopharmaceutical company focused on the discovery,
development and manufacturing of human therapeutic antibodies. The company's
antibody development platform includes a leading technology and
state-of-the-art manufacturing capabilities that enable the rapid generation,
selection and production of high affinity, fully human antibody product
candidates to a variety of disease targets. Abgenix leverages its leadership
position in human antibody technology to build a diversified product portfolio
through its own development efforts and through the establishment of
collaborations with multiple pharmaceutical and biotechnology companies. For
more information on Abgenix, visit the company's website at http://www.abgenix.com.
SOURCE Abgenix, Inc.
 back to top
Related links:
http://www.abgenix.com
CONTACT:
Ami Knoefler, Senior Director, Corporate
Communications and Investor Relations of Abgenix, Inc.,
+1-510-284-6350 or +1-510-284-6605
|
